The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Stefan Verheye
Showing 1-20 of 46 articles
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry
Wlodarczak A,
Montorsi P,
Torzewski J,
Bennett J,
Starmer G,
Buck T,
Haude M,
Moccetti M,
Wiemer M,
Lee M,
Verheye S
May 24, 2023 | 10.4244/EIJ-D-22-01069
Evaluation of the R-One robotic system for percutaneous coronary intervention: the R-EVOLUTION study
Durand E,
Sabatier R,
Smits P,
Verheye S,
Pereira B,
Fajadet J
April 3, 2023 | 10.4244/EIJ-D-22-00642
Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)
Verheye S,
Agostoni P,
Giannini F,
Hill J,
Jensen C,
Lindsay S,
Stella P,
Redwood S,
Banai S,
Konigstein M
September 20, 2021 | 10.4244/EIJ-D-20-00873
Effects of coronary sinus Reducer implantation on oxygen kinetics in patients with refractory angina
Zivelonghi C,
Konigstein M,
Azzano A,
Agostoni P,
Topilski Y,
Banai S,
Verheye S
April 2, 2021 | 10.4244/EIJ-D-19-00766
Reply: Pitfalls in aerobic capacity estimation of a chronic angina population
Zivelonghi C,
Verheye S
March 19, 2021 | 10.4244/EIJ-D-20-00676R
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
Verheye S,
Vrolix M,
Montorfano M,
Zivelonghi C,
Giannini F,
Bedogni F,
Dubois C,
De Bruyne B,
Costa R,
Chamié D,
de Ribamar Costa J,
Kereiakes D,
Abizaid A,
Colombo A
December 18, 2020 | 10.4244/EIJ-D-20-00763
Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry
Verheye S,
Wlodarczak A,
Montorsi P,
Bennett J,
Torzewski J,
Haude M,
Vrolix M,
Buck T,
Aminian A,
van der Schaaf R,
Nuruddin A,
Lee M
February 7, 2020 | 10.4244/EIJ-D-18-01058
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions
Verheye S,
Costa R,
Schofer J,
Ormiston J,
Maeng M,
Dudek D,
Skurk C,
Botelho R,
Costa J,
Chamié D,
Abizaid An,
Boersma E,
Abizaid A
October 18, 2019 | 10.4244/EIJ-D-18-00292
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Dubois C,
Dens J,
Farah B,
Carrié D,
Walsh S,
Oldroyd K,
Varenne O,
El-Jack S,
Moreno R,
Christen T,
Allocco D
April 20, 2018 | 10.4244/EIJ-D-17-00529
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials
Wijns W,
Vrolix M,
Verheye S,
Schoors D,
Slagboom T,
Gosselink M,
Benit E,
Kandzar D,
Donohoe D,
Ormiston J
April 6, 2018 | 10.4244/EIJ-D-17-00230
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude M,
Ince H,
Kische S,
Abizaid A,
Toelg R,
Lemos P,
Van Mieghem N,
Verheye S,
von Birgelen C,
Christiansen E,
Wijns W,
Garcia-Garcia H,
Waksman R
July 20, 2017 | 10.4244/EIJ-D-17-00254
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial
Iqbal J,
Verheye S,
Abizaid A,
Ormiston J,
De Vries T,
Morrison L,
Toyloy S,
Fitzgerald P,
Windecker S,
Serruys P
December 9, 2016 | 10.4244/EIJY15M10_04
Cryotherapy increases features of plaque stability in atherosclerotic rabbits
Verheye S,
Roth L,
De Meyer I,
Van Hove C,
Nahon D,
Santoianni D,
Yianni J,
Martinet W,
Buchbinder M,
De Meyer G
August 20, 2016 | 10.4244/EIJY15M10_02
Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising the Svelte coronary stent-on-a-wire: the DIRECT II study
Verheye S,
Khattab A,
Carrié D,
Stella P,
Slagboom T,
Bartunek J,
Onuma Y,
Serruys P
August 5, 2016 | 10.4244/EIJV12I5A101
Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
Haude M,
Erbel R,
Erne P,
Verheye S,
Degen H,
Vermeersch P,
Weissman N,
Prati F,
Bruining N,
Waksman R,
Koolen J
June 10, 2016 | 10.4244/EIJ-D-15-00371
Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system
Verheye S,
Buysschaert I,
Grube E
December 20, 2015 | 10.4244/EIJV11I8A176
Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study
Nakatani S,
Onuma Y,
Ishibashi Y,
Karanasos A,
Regar E,
Garcia-Garcia H,
Tamburino C,
Fajadet J,
Vrolix M,
Witzenbichler B,
Eeckhout E,
Spaulding C,
Reczuch K,
La Manna A,
Spaargaren R,
Capodanno D,
van Langenhove G,
Verheye S,
Serruys P,
van Geuns R
December 20, 2015 | 10.4244/EIJY15M11_01
Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial
Thomas M,
Nienaber C,
Naber C,
Ince H,
Erglis A,
Vukcevic V,
Schäfer U,
Ferreira R,
Hardt S,
Verheye S,
Ribeiro V,
Sugeng L,
Tamburino C
October 20, 2015 | 10.4244/EIJV11I6A143
A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study
Barbato E,
Salinger-Martinovic S,
Sagic D,
Beleslin B,
Vrolix M,
Neskovic A,
Jagic N,
Verheye S,
Mehmedbegovic Z,
Wijns W
September 22, 2015 | 10.4244/EIJY14M08_06
The Tiara transcatheter mitral valve implantation system
Verheye S,
Cheung A,
Leon MB,
Banai S
September 17, 2015 | 10.4244/EIJV11SWA20
1
2
3
Latest news
AHEAD OF PRINT
Ostial RCA ISR: mechanisms and treatment outcomes
FREE ARTICLE - Kei Yamamoto et al
June 7, 2023
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
NEW ISSUE
Expert Review on Calcified CTOs; Calcified Nodules Revascularisation Debate; CTO PCI; Stent Failure and Calcified Nodules and more...
June 5, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke